Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Spanish Adaptation and Validation of the Outcome Questionnaire OQ-30.2.

Errázuriz P, Opazo S, Behn A, Silva O, Gloger S.

Front Psychol. 2017 May 16;8:673. doi: 10.3389/fpsyg.2017.00673. eCollection 2017.

2.

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.

O'Connor P, Comi G, Freedman MS, Miller AE, Kappos L, Bouchard JP, Lebrun-Frenay C, Mares J, Benamor M, Thangavelu K, Liang J, Truffinet P, Lawson VJ, Wolinsky JS; Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group and the MRI-AC in Houston, Texas.

Neurology. 2016 Mar 8;86(10):920-30. doi: 10.1212/WNL.0000000000002441. Epub 2016 Feb 10. Erratum in: Neurology. 2016 Oct 4;87(14 ):1524.

3.

Acceptability Study of "Ascenso": An Online Program for Monitoring and Supporting Patients with Depression in Chile.

Espinosa HD, Carrasco Á, Moessner M, Cáceres C, Gloger S, Rojas G, Perez JC, Vanegas J, Bauer S, Krause M.

Telemed J E Health. 2016 Jul;22(7):577-83. doi: 10.1089/tmj.2015.0124. Epub 2016 Jan 7.

PMID:
26741190
4.

Oestradiol-induced synapse formation in the female hippocampus: roles of oestrogen receptor subtypes.

Zhou L, Fester L, Haghshenas S, de Vrese X, von Hacht R, Gloger S, Brandt N, Bader M, Vollmer G, Rune GM.

J Neuroendocrinol. 2014 Jul;26(7):439-47. doi: 10.1111/jne.12162.

PMID:
24779550
5.

The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.

Grossberg GT, Manes F, Allegri RF, Gutiérrez-Robledo LM, Gloger S, Xie L, Jia XD, Pejović V, Miller ML, Perhach JL, Graham SM.

CNS Drugs. 2013 Jun;27(6):469-78. doi: 10.1007/s40263-013-0077-7.

6.

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.

Wolinsky JS, Narayana PA, Nelson F, Datta S, O'Connor P, Confavreux C, Comi G, Kappos L, Olsson TP, Truffinet P, Wang L, Miller A, Freedman MS; Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group.

Mult Scler. 2013 Sep;19(10):1310-9. doi: 10.1177/1352458513475723. Epub 2013 Feb 27.

PMID:
23447359
7.

The CUIDEME Study: determinants of burden in chilean primary caregivers of patients with dementia.

Slachevsky A, Budinich M, Miranda-Castillo C, Núñez-Huasaf J, Silva JR, Muñoz-Neira C, Gloger S, Jimenez O, Martorell B, Delgado C.

J Alzheimers Dis. 2013;35(2):297-306. doi: 10.3233/JAD-122086.

PMID:
23422358
8.

Aromatase inhibition abolishes LTP generation in female but not in male mice.

Vierk R, Glassmeier G, Zhou L, Brandt N, Fester L, Dudzinski D, Wilkars W, Bender RA, Lewerenz M, Gloger S, Graser L, Schwarz J, Rune GM.

J Neurosci. 2012 Jun 13;32(24):8116-26. doi: 10.1523/JNEUROSCI.5319-11.2012.

9.

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

O'Connor P, Wolinsky JS, Confavreux C, Comi G, Kappos L, Olsson TP, Benzerdjeb H, Truffinet P, Wang L, Miller A, Freedman MS; TEMSO Trial Group.

N Engl J Med. 2011 Oct 6;365(14):1293-303. doi: 10.1056/NEJMoa1014656.

10.

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH; EMBOLDEN II (Trial D1447C00134) Investigators.

J Clin Psychiatry. 2010 Feb;71(2):163-74. doi: 10.4088/JCP.08m04942gre. Epub 2010 Jan 26.

PMID:
20122366
11.

Refractory depression in a patient with peripheral resistance to thyroid hormone (RTH) and the effect of triiodothyronine treatment.

Fardella CE, Artigas RA, Gloger S, Jiménez M, Carvajal CA, Krall PM, Quiroz D, Campino C, Mosso LM.

Endocrine. 2007 Jun;31(3):272-8.

PMID:
17906375
12.

[High prevalence of thyroid dysfunction among psychiatric inpatients].

Valdivieso F S, Kripper C, Ivelic JA, Fardella C, Gloger S, Quiroz D.

Rev Med Chil. 2006 May;134(5):623-8. Epub 2006 Jun 19. Spanish.

13.

[Mood disorders, psychopharmacology and thyroid hormones].

Danilo Q, Gloger S, Valdivieso S, Ivelic J, Fardella C.

Rev Med Chil. 2004 Nov;132(11):1413-24. Review. Spanish.

PMID:
15693206
14.

Neurobehavioral and psychological changes induced by hyperthyroidism: diagnostic and therapeutic implications.

Fardella CE, Gloger S.

Expert Rev Neurother. 2002 Sep;2(5):709-16. doi: 10.1586/14737175.2.5.709.

PMID:
19810987
15.

[Panic disorder and hyperthyroidism. Report of 2 cases].

Gloger S, Fardella C, Gajardo C, Figueroa R, Salgado C, Santis R, Barroilhet S.

Rev Med Chil. 2001 Feb;129(2):187-90. Spanish.

PMID:
11351471
16.

[High prevalence of subclinical thyroidal disease among individuals attended in health control].

Fardella C, Poggi H, Gloger S, Rojas A, Velasquez CG, Barroileth S, Figueroa R, Alvarez C, Salgado C, Gajardo C, Foradori A, Montero J.

Rev Med Chil. 2001 Feb;129(2):155-60. Spanish.

PMID:
11351466
17.

High prevalence of thyroid abnormalities in a Chilean psychiatric outpatient population.

Fardella C, Gloger S, Figueroa R, Santis R, Gajardo C, Salgado C, Barroilhet S, Foradori A.

J Endocrinol Invest. 2000 Feb;23(2):102-6.

PMID:
10800763
18.

Subacute liver failure induced by phenprocoumon treatment.

Mix H, Wagner S, Böker K, Gloger S, Oldhafer KJ, Behrend M, Flemming P, Manns MP.

Digestion. 1999 Nov-Dec;60(6):579-82.

PMID:
10545730
19.

[Relevance of the thyroid function assessment in psychiatric patients].

Gloger S, Fardella C, Santis R, Bitrán J.

Rev Med Chil. 1997 Nov;125(11):1351-6. Spanish.

PMID:
9609057
20.

[Immune response reduced by intense intellectual stress: changes in lymphocyte proliferation in medical students].

Gloger S, Puente J, Arias P, Fischman P, Caldumbide I, González R, Quiroz J, Echavarri O, Ramírez C.

Rev Med Chil. 1997 Jun;125(6):665-70. Spanish.

PMID:
9515285

Supplemental Content

Loading ...
Support Center